文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

体外生命支持在成人危重症患者中的应用:呼吸与心脏衰竭中的获益机制

Extracorporeal life support in adult critically ill patients: mechanisms of benefit in respiratory and cardiac failure.
PubMed 文献 · Am J Respir Crit Care Med · 2026-01-01
一句话结论本综述阐述体外生命支持通过恢复气体交换、优化循环动力学和减轻继发性器官损伤,在呼吸和/或心脏衰竭中可能产生获益的机制。

本综述探讨体外生命支持在成人严重、潜在可逆的呼吸和/或心脏衰竭中对传统措施无效时的获益机制。在孤立性呼吸衰竭中,呼吸体外生命支持稳定气体交换并调节呼吸驱动,实现肺保护性通气,可能减轻呼吸机相关和患者自发性肺损伤。在心源性休克中,心脏体外生命支持恢复全身灌注并可能降低心肌氧耗,在心脏骤停期间可能产生神经保护作用。在合并心肺衰竭中,高级体外支持模式可增强全身和肺循环,支持气体交换并维持终末器官灌注。机制上,这些干预中断低氧血症和/或高碳酸血症诱导的肺血管收缩、右心室负荷过重和全身灌注不足的级联反应,促进多器官恢复。优化患者选择、启动时机和辅助治疗需要理解这些生理通路间的相互作用,并考虑设备相关并发症、血液学和炎症扰动及生理权衡等关键局限性。

要点

  • 在孤立性呼吸衰竭中,呼吸体外生命支持稳定气体交换并调节呼吸驱动,实现肺保护性通气,可能减轻呼吸机相关和患者自发性肺损伤。
  • 在心源性休克中,心脏体外生命支持恢复全身灌注并可能降低心肌氧耗。
  • 在心脏骤停期间,体外生命支持可能产生神经保护作用。
  • 在合并心肺衰竭中,高级体外支持模式可增强全身和肺循环,支持气体交换并维持终末器官灌注。
  • 机制上,体外生命支持中断低氧血症和/或高碳酸血症诱导的肺血管收缩、右心室负荷过重和全身灌注不足的级联反应,促进多器官恢复。

适用人群与场景

  • 成人危重症患者,患有严重、潜在可逆的呼吸和/或心脏衰竭,对传统措施无效。

研究设计与关键结果

  • 本综述综合当前文献,探讨体外生命支持在成人呼吸和心脏衰竭中获益的机制基础。

证据类型、等级与局限

  • 证据类型:最先进综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 优化患者选择、体外生命支持启动时机和辅助治疗的使用,需要细致理解这些生理通路间的相互作用,并仔细考虑关键局限性,包括设备相关并发症、血液学和炎症扰动及生理权衡。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Extracorporeal life support provides temporary cardiorespiratory support for patients with severe, potentially reversible cardiac and/or respiratory failure refractory to conventional measures. Its application has broadened across a wide spectrum of critical illness, yet the mechanistic basis of its physiologic benefit remains incompletely defined. This review explores the mechanisms through which extracorporeal life support may confer benefit in respiratory and cardiac failure. These include restoration of gas exchange, optimization of circulatory dynamics, and mitigation of secondary organ injuries, creating conditions that facilitate tissue repair, enable adjunctive therapies, and, in selected cases, provide a bridge to transplantation. In isolated respiratory failure, respiratory extracorporeal life support stabilizes gas exchange and modulates respiratory drive, enabling lung-protective ventilation and potentially attenuating ventilator- and patient self-inflicted lung injury. In cardiogenic shock, cardiac extracorporeal life support restores systemic perfusion and may reduce myocardial oxygen demand, while during cardiac arrest, it may confer neuroprotective effects. In combined cardiorespiratory failure, advanced extracorporeal support modalities may augment both systemic and pulmonary circulation, supporting gas exchange and maintaining end-organ perfusion. Mechanistically, these interventions interrupt the cascade of hypoxemia- and/or hypercapnia- induced pulmonary vasoconstriction, right ventricular overload, and systemic hypoperfusion, facilitating multiorgan recovery. Optimizing patient selection, timing for extracorporeal life support initiation, and use of adjunctive therapies require a nuanced understanding of the interplay between these physiologic pathways alongside careful considerations of key limitations, including device-related complications, hematologic and inflammatory perturbations, and physiologic trade-offs. This State-of-the-Art review synthesizes the current literature on the mechanistic basis of extracorporeal life support in adults.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Zochios V, Brewer JM, Antonini MV, et al. Extracorporeal life support in adult critically ill patients: mechanisms of benefit in respiratory and cardiac failure. Am J Respir Crit Care Med. 2026. PMID: 42320025. doi:10.1093/ajrccm/aamag321

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。